Damien Conover
Damien Conover is Director of Healthcare Equity Research and Equity Strategy at Morningstar. He is responsible for overseeing equity coverage of companies in the healthcare sector as well as guiding the overall strategy for the equity research business. Prior to this current role, he served as an equity strategist at Morningstar, mainly covering large-cap pharmaceutical companies. Having covered the healthcare sector for more than 10 years, Conover is now a recognized expert in healthcare investing, with a primary focus on pharmaceutical and biotechnology companies.
Damien Conover Professional Experience / Academic History
Professional Experience
-
Director of Healthcare Equity Research and Equity Strategy
-
Equity Strategist
-
Analyst
Academic History
-
Master's Degree in Finance
-
Bachelor's Degree in Finance
INVESTMENT STATEMENT
"Using a long-term outlook and emphasizing economic moats, or sustainable competitive advantages, I strive to create differentiated research that has supported long-term outperformance."
SPECIALTIES
- Equity research
- Cash flow modeling
- Identifying investment opportunities
- Pharmaceutical and biotechnology analysis
CAREER
- Responsible for team stock recommendations, research quality and consistency, and analyst development.
- Made research contributions towards the firm's overall moat methodology.
- Led the Healthcare Observer reports.
Analyst at Raymond James Financial
- Analyzed equity securities across all sectors and industries.
- Developed investment views through fundamental and quantitative research for various funds.
Analyst at Clearwater Asset Management
- Co-managed a growth portfolio and multi-strategy hedge fund on behalf of institutional clients.
- Developed investment ideas through fundamental and quantitative research on equity investments.
- Identified the valuation and investment opinion for securities within the healthcare sector.
- Advised sales and trading departments along with institutional clients on investment opinions.
MEDIA
- Conover appears regularly on Bloomberg TV, CNBC and CNN.
- He has appeared as a guest on Real Vision.